Author

Eliana K. Asciutto

Consejo Nacional de Investigaciones Científicas y TécnicasORCID 0000-0002-8931-027XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Míriam RoyoiD· 2 shared Pablo ScodelleriD· 2 shared Tambet TeesaluiD· 2 shared Alberto Guillermo Arias· 1 shared Aman P. ManniD· 1 shared Anni LeplandiD· 1 shared Cristian Roberto SmulskiiD· 1 shared Elisa PeranzoniiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Míriam RoyoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Therapeutic Tumor Macrophage Reprogramming in Breast Cancer Through a Peptide-Drug Conjugate

Anni Lepland, Elisa Peranzoni, Uku Haljasorg, Eliana K. Asciutto, Maria Crespí‐Amer, Lorenzo Modesti, Kalle Kilk, Manuel Lombardía, Gerardo Acosta, Míriam Royo, Pärt Peterson, Ilaria Marigo, Tambet Teesalu, Pablo Scodeller

This paper develops a peptide-drug conjugate, MACTIDE-V, that reprograms tumor-associated macrophages in breast cancer, reducing metastasis and enhancing anti-tumor immunity.

Advanced Science · Jan 22, 2025Peer-reviewedCancer Biology

A CYCLIC PEPTIDE TARGETS GLIOBLASTOMA BY BINDING TO ABERRANTLY EXPOSED SNAP25

Alberto Guillermo Arias, Laura Tovar-Martinez, Eliana K. Asciutto, Aman P. Mann, Kristina Põšnograjeva, Lorena Simón‐Gracia, Míriam Royo, Maarja Haugas, Tambet Teesalu, Cristian Roberto Smulski, Erkki Ruoslahti, Pablo Scodeller

This paper identifies a cyclic peptide, CES, that targets glioblastoma by binding to aberrantly exposed SNAP25, showing its potential as a drug delivery tool and molecular marker.

Molecular Pharmaceutics · Nov 22, 2024Peer-reviewedCancer Biology